A nomogram for predicting metabolic-associated fatty liver disease in non-obese newly diagnosed type 2 diabetes patients
The nomogram demonstrated effectiveness as a screening tool for evaluating the risk of MAFLD in T2DM individuals without obesity, facilitating early identification and supporting enhanced management strategies for MAFLD.
Authors
- Yuliang Cui
- Fenghua Li (ORCID: https://orcid.org/0000-0002-3211-012X)
- Yunyun Cheng (ORCID: https://orcid.org/0000-0003-3166-5534)
- Tingting Li (ORCID: https://orcid.org/0000-0003-4583-946X)
- Haiyan Shi (ORCID: https://orcid.org/0000-0002-4984-1850)
- Wanjing Sun
Institutions
- Qilu Hospital of Shandong University (CN)
- Dezhou University (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-05-29
- DOI
- https://doi.org/10.3389/fendo.2025.1521168
- Citations
- 5
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 6.77
Funders
- Natural Science Foundation of Shandong Province